Literature DB >> 12065073

Influence of some beta-adrenoceptor antagonists on the anticonvulsant potency of antiepileptic drugs against audiogenic seizures in DBA/2 mice.

Giovambattista De Sarro1, Eugenio Donato Di Paola, Guido Ferreri, Angela De Sarro, Wolfgang Fischer.   

Abstract

The two enantiomers of propranolol antagonize generalized tonic-clonic seizures in DBA/2 mice with the (-)-enantiomer being about 1.5 times more potent than the (+)-enantiomer. Metoprolol was less active and atenolol was unable to affect audiogenic seizures. In combination with conventional antiepileptic drugs, both propranolol enantiomers tested in doses not affecting the occurrence of audiogenic seizures increased the anticonvulsant activity of diazepam, phenobarbital, valproate and lamotrigine and tended to increase that of carbamazepine and phenytoin. The effect was more pronounced with the (-)-enantiomer. This increase was associated with an enhancement of motor impairment, however, the therapeutic index of combined treatment of the antiepileptic drugs with both propranolol enantiomers was more favourable than the combination with saline alone. Metoprolol was also able to decrease the ED(50) values of the antiepileptic drugs, whereas atenolol showed no effects. Since neither enantiomer of propranolol significantly influenced the total and free plasma levels of the antiepileptics, pharmacokinetic interactions are not likely. In addition, (+)- and (-)-propranolol did not significantly affect the hypothermic effects of the antiepileptics tested. In conclusion, both enantiomers of propranolol and metoprolol showed an additive anticonvulsant effect when co-administered with some conventional antiepileptic drugs, most notably diazepam, phenobarbital, lamotrigine and valproate, implicating a possible therapeutic relevance of such drug combinations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065073     DOI: 10.1016/s0014-2999(02)01536-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  Redistribution of monocarboxylate transporter 2 on the surface of astrocytes in the human epileptogenic hippocampus.

Authors:  Fredrik Lauritzen; Kjell Heuser; Nihal C de Lanerolle; Tih-Shih W Lee; Dennis D Spencer; Jung H Kim; Albert Gjedde; Tore Eid; Linda H Bergersen
Journal:  Glia       Date:  2012-04-25       Impact factor: 7.452

2.  Autonomic and cellular mechanisms mediating detrimental cardiac effects of status epilepticus.

Authors:  Steven L Bealer; Jason G Little; Cameron S Metcalf; Amy L Brewster; Anne E Anderson
Journal:  Epilepsy Res       Date:  2010-07-21       Impact factor: 3.045

Review 3.  Monoaminergic Mechanisms in Epilepsy May Offer Innovative Therapeutic Opportunity for Monoaminergic Multi-Target Drugs.

Authors:  Dubravka Svob Strac; Nela Pivac; Ilse J Smolders; Wieslawa A Fogel; Philippe De Deurwaerdere; Giuseppe Di Giovanni
Journal:  Front Neurosci       Date:  2016-11-10       Impact factor: 4.677

4.  Interactions of Mexiletine with Novel Antiepileptic Drugs in the Maximal Electroshock Test in Mice: An Isobolographic Analysis.

Authors:  Dorota Wróblewska; Monika Rudkowska; Monika Banach; Kinga K Borowicz-Reutt
Journal:  Neurochem Res       Date:  2018-08-16       Impact factor: 3.996

5.  Nebivolol attenuates the anticonvulsant action of carbamazepine and phenobarbital against the maximal electroshock-induced seizures in mice.

Authors:  Kinga K Borowicz-Reutt; Monika Banach; Monika Rudkowska
Journal:  Pharmacol Rep       Date:  2019-12-20       Impact factor: 3.024

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.